Texas Sues Insulin Manufacturers and PBMs for Price Inflation

Attorney General Ken Paxton accuses companies of conspiring to raise insulin prices, impacting diabetes patients.

Texas Attorney General Ken Paxton has filed a lawsuit against major insulin manufacturers Eli Lilly, Novo Nordisk, and Sanofi.
The lawsuit also targets pharmacy benefit managers (PBMs) such as CVS' Caremark, Cigna's Express Scripts, and UnitedHealth's OptumRx.
Paxton alleges that insulin prices were artificially inflated through a conspiracy between drug manufacturers and PBMs.
Insulin manufacturers reportedly paid PBMs for preferential treatment, leading to higher list prices and exclusion of cheaper alternatives.
The lawsuit follows a similar action by the Federal Trade Commission against PBMs but expands the focus to include drug manufacturers.